Daily Regimens: The 1000 mcg Approach A daily 1000 mcg Vitamin B12 dose is often suggested for neuropathy
Furthermore, IM administration of hydroxocobalamin is also the preferred treatment for pediatric patients with intrinsic cobalamin metabolic diseases
AOD-9604's pivotal Phase 2b trial failed its primary endpoint: 536 participants, 24 weeks, no statistically significant fat loss versus placebo
The single most important framing: efficacy figures for this molecule come from cell and animal studies , so any timeline is a research expectation, not a guaranteed outcome
Deficiency may also result from poor absorption, which may increase as we age
It has moved from academic laboratories into research-chemical supply, labelled for research use only